Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare Inc (NYSE:HCA) and Ironwood Pharma (NASDAQ:IRWD).
HCA Healthcare Inc (HCA)
In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on HCA Healthcare Inc, with a price target of $135. The company’s shares closed yesterday at $129.
France noted:
“We rate HCA Overweight. Despite weaker results at other providers, particularly smaller, rural names, HCA has continued to report better than average volume and profitability, reflecting its larger urban hospitals and more sophisticated case load. We believe that HCA’s outlook will continue to produce outperformance relative to the group, and hope to learn more about the implications of today’s results on this morning’s earnings call.”
According to TipRanks.com, France is a 5-star analyst with an average return of 10.2% and a 58.1% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.
Currently, the analyst consensus on HCA Healthcare Inc is a Strong Buy with an average price target of $148.73, implying a 15.3% upside from current levels. In a report released today, Oppenheimer also maintained a Buy rating on the stock.
.
See today’s analyst top recommended stocks >>
Ironwood Pharma (IRWD)
Cowen & Co. analyst Boris Peaker maintained a Hold rating on Ironwood Pharma today and set a price target of $21. The company’s shares closed yesterday at $16.09.
According to TipRanks.com, Peaker is a 4-star analyst with an average return of 6.6% and a 39.4% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals Inc, Stemline Therapeutics Inc, and Mersana Therapeutics Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ironwood Pharma with a $20.88 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
